Analyst Mohit Bansal of Wells Fargo maintained a Hold rating on Halozyme (HALO – Research Report), retaining the price target of $62.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback